Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD. Consensus on diagnosis and management of Cushing's disease: a guideline update. The lancet Diabetes & Endocrinology 2021, 9(12):847-875.
Qiao N, Swearingen B, Hedley-Whyte ET, Tritos NA. The utility of intraoperative cytological smear and frozen section in the surgical management of patients with Cushing’s disease due to pituitary microadenomas. Endocrine Pathology 2019, 30:180-188.
Asa SL, Mete O, Perry A, Osamura RY. Overview of the 2022 WHO classification of pituitary tumors. Endocrine Pathology 2022, 33(1):6-26.
Article CAS PubMed Google Scholar
Asa SL, Mete O, Ezzat S. Genomics and epigenomics of pituitary tumors: what do pathologists need to know? Endocrine pathology 2021, 32:3-16.
Mete O, Asa SL. Clinicopathological correlations in pituitary adenomas. Brain pathology 2012, 22(4):443-453.
Article PubMed PubMed Central Google Scholar
Saeger W, Geisler F, Lüdecke D. Pituitary pathology in Cushing's disease. Pathology-Research and Practice 1988, 183(5):592-595.
Article CAS PubMed Google Scholar
Reuss WA, Saeger W, Lüdecke DK. Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing's disease and Nelson's syndrome. Virchows Archiv A 1991, 419:395-401.
Doğanşen SÇ, Bilgiç B, Yalin GY, Tanrikulu S, Yarman S. Clinical significance of granulation pattern in corticotroph pituitary adenomas. Turk Patoloji Derg 2019, 35(1):9-14.
Rak B, Maksymowicz M, Pękul M, Zieliński G. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing’s Disease. Frontiers in endocrinology 2021:564.
Witek P, Zieliński G, Szamotulska K, Maksymowicz M, Kamiński G. Clinicopathological predictive factors in the early remission of corticotroph pituitary macroadenomas in a tertiary referral centre. European Journal of Endocrinology 2016, 174(4):539.
Article CAS PubMed PubMed Central Google Scholar
Hayashi K, Inoshita N, Kawaguchi K, Ibrahim Ardisasmita A, Suzuki H, Fukuhara N, Okada M, Nishioka H, Takeuchi Y, Komada M. The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease. European Journal of Endocrinology 2016, 174(2):213-226.
Article CAS PubMed Google Scholar
Pivonello R, De Martino MC, De Leo M, Simeoli C, Colao A. Cushing’s disease: the burden of illness. Endocrine 2017, 56(1):10-18.
Article CAS PubMed Google Scholar
Perez-Vega C, Ramos-Fresnedo A, Tripathi S, Domingo RA, Ravindran K, Almeida JP, Peterson J, Trifiletti DM, Chaichana KL, Quinones-Hinojosa A. Treatment of recurrent and persistent Cushing’s disease after first transsphenoidal surgery: lessons learned from an international meta-analysis. Pituitary 2022, 25(3):540-549.
Dai C, Fan Y, Liu X, Bao X, Yao Y, Wang R, Feng M. Predictors of Immediate Remission after Surgery in Cushing’s Disease Patients: a large retrospective study from a single center. Neuroendocrinology 2021, 111(11):1141-1150.
Article CAS PubMed Google Scholar
Kuritsyna NV, Tsoy UA, Cherebillo VY, Paltsev AA, Ryzhkov AV, Ryazanov PA, Ryzhkov VK, Grineva EN. A Comprehensive Approach to Predicting the Outcomes of Transsphenoidal Endoscopic Adenomectomy in Patients with Cushing’s Disease. Journal of Personalized Medicine 2022, 12(5):798.
Article PubMed PubMed Central Google Scholar
Aranda G, Enseñat J, Mora M, Puig-Domingo M, Martínez de Osaba M, Casals G, Verger E, Ribalta M, Hanzu F, Halperin I. Long-term remission and recurrence rate in a cohort of Cushing’s disease: the need for long-term follow-up. Pituitary 2015, 18(1):142-149.
Article CAS PubMed Google Scholar
McCance D, Gordon D, Fannin T, Hadden D, Kennedy L, Sheridan B, Atkinson A. Assessment of endocrine function after transsphenoidal surgery for Cushing's disease. Clinical Endocrinology 1993, 38(1):79-86.
Article CAS PubMed Google Scholar
Nishioka H, Yamada S. Cushing’s disease. Journal of clinical medicine 2019, 8(11):1951.
Article CAS PubMed Google Scholar
Akirov A, Larouche V, Shimon I, Asa SL, Mete O, Sawka AM, Gentili F, Ezzat S. Significance of Crooke's hyaline change in nontumorous corticotrophs of patients with Cushing disease. Frontiers in Endocrinology 2021, 12:620005.
Article PubMed PubMed Central Google Scholar
Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism 2008, 93(5):1526-1540.
Capatina C, Hinojosa-Amaya JM, Poiana C, Fleseriu M. Management of patients with persistent or recurrent Cushing’s disease after initial pituitary surgery. Expert Review of Endocrinology & Metabolism 2020, 15(5):321-339.
Potorac I, Petrossians P, Daly AF, Schillo F, Ben Slama C, Nagi S, Sahnoun M, Brue T, Girard N, Chanson P. Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences. Endocr Relat Cancer 2015, 22(2):169-177.
Article CAS PubMed Google Scholar
Aslan K, Gunbey HP, Tomak L, Incesu L. The diagnostic value of using combined MR diffusion tensor imaging parameters to differentiate between low-and high-grade meningioma. The British journal of radiology 2018, 91(1088):20180088.
Article PubMed PubMed Central Google Scholar
Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 1993, 33(4):610-618.
Di Ieva A, Rotondo F, Syro LV, Cusimano MD, Kovacs K. Aggressive pituitary adenomas—diagnosis and emerging treatments. Nature Reviews Endocrinology 2014, 10(7):423-435.
Hardy J. The transsphenoidal surgical approach to the pituitary. Hospital practice 1979, 14(6):81-89.
Article CAS PubMed Google Scholar
Winston GP, Vos SB, Burdett JL, Cardoso MJ, Ourselin S, Duncan JS. Automated T2 relaxometry of the hippocampus for temporal lobe epilepsy. Epilepsia 2017, 58(9):1645-1652.
Article PubMed PubMed Central Google Scholar
Mete O, Lopes MB. Overview of the 2017 WHO classification of pituitary tumors. Endocrine Pathology 2017, 28:228-243.
Article CAS PubMed Google Scholar
Mete O, Asa SL. Structure, function, and morphology in the classification of pituitary neuroendocrine tumors: the importance of routine analysis of pituitary transcription factors. Endocrine Pathology 2020, 31:330-336.
Mete O, Ezzat S, Perry A, Yamada S, Uccella S, Grossman AB, Asa SL. The pangenomic classification of pituitary neuroendocrine tumors: quality histopathology is required for accurate translational research. Endocrine Pathology 2021, 32:415-417.
Asa SL. Challenges in the diagnosis of pituitary neuroendocrine tumors. Endocrine Pathology 2021, 32(2):222-227.
Woo YS, Isidori AM, Wat WZ, Kaltsas GA, Afshar F, Sabin I, Jenkins PJ, Monson JP, Besser GM, Grossman AB. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas. The Journal of Clinical Endocrinology & Metabolism 2005, 90(8):4963-4969.
Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Müller OA, Fahlbusch R. Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. Journal of neurosurgery 2008, 108(1):9-18.
留言 (0)